Pharmaceutical CDMO Services Market - Global Outlook and Forecast 2024-2031

Report ID: 1566594 | Published Date: Jan 2025 | No. of Page: 63 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story
1 Introduction to Research & Analysis Reports
    1.1 Pharmaceutical CDMO Services Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Pharmaceutical CDMO Services Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Pharmaceutical CDMO Services Overall Market Size
    2.1 Global Pharmaceutical CDMO Services Market Size: 2021 VS 2028
    2.2 Global Pharmaceutical CDMO Services Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Pharmaceutical CDMO Services Players in Global Market
    3.2 Top Global Pharmaceutical CDMO Services Companies Ranked by Revenue
    3.3 Global Pharmaceutical CDMO Services Revenue by Companies
    3.4 Top 3 and Top 5 Pharmaceutical CDMO Services Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Pharmaceutical CDMO Services Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Pharmaceutical CDMO Services Players in Global Market
        3.6.1 List of Global Tier 1 Pharmaceutical CDMO Services Companies
        3.6.2 List of Global Tier 2 and Tier 3 Pharmaceutical CDMO Services Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Pharmaceutical CDMO Services Market Size Markets, 2021 & 2028
        4.1.2 Drug Substance Development and Manufacturing
        4.1.3 Specialized Services
        4.1.4 Lab-based Services
    4.2 By Type - Global Pharmaceutical CDMO Services Revenue & Forecasts
        4.2.1 By Type - Global Pharmaceutical CDMO Services Revenue, 2017-2022
        4.2.2 By Type - Global Pharmaceutical CDMO Services Revenue, 2023-2028
        4.2.3 By Type - Global Pharmaceutical CDMO Services Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Pharmaceutical CDMO Services Market Size, 2021 & 2028
        5.1.2 Innovative Medicine
        5.1.3 Patented Drug
        5.1.4 Patent Expired Drug
    5.2 By Application - Global Pharmaceutical CDMO Services Revenue & Forecasts
        5.2.1 By Application - Global Pharmaceutical CDMO Services Revenue, 2017-2022
        5.2.2 By Application - Global Pharmaceutical CDMO Services Revenue, 2023-2028
        5.2.3 By Application - Global Pharmaceutical CDMO Services Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Pharmaceutical CDMO Services Market Size, 2021 & 2028
    6.2 By Region - Global Pharmaceutical CDMO Services Revenue & Forecasts
        6.2.1 By Region - Global Pharmaceutical CDMO Services Revenue, 2017-2022
        6.2.2 By Region - Global Pharmaceutical CDMO Services Revenue, 2023-2028
        6.2.3 By Region - Global Pharmaceutical CDMO Services Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Pharmaceutical CDMO Services Revenue, 2017-2028
        6.3.2 US Pharmaceutical CDMO Services Market Size, 2017-2028
        6.3.3 Canada Pharmaceutical CDMO Services Market Size, 2017-2028
        6.3.4 Mexico Pharmaceutical CDMO Services Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Pharmaceutical CDMO Services Revenue, 2017-2028
        6.4.2 Germany Pharmaceutical CDMO Services Market Size, 2017-2028
        6.4.3 France Pharmaceutical CDMO Services Market Size, 2017-2028
        6.4.4 U.K. Pharmaceutical CDMO Services Market Size, 2017-2028
        6.4.5 Italy Pharmaceutical CDMO Services Market Size, 2017-2028
        6.4.6 Russia Pharmaceutical CDMO Services Market Size, 2017-2028
        6.4.7 Nordic Countries Pharmaceutical CDMO Services Market Size, 2017-2028
        6.4.8 Benelux Pharmaceutical CDMO Services Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Pharmaceutical CDMO Services Revenue, 2017-2028
        6.5.2 China Pharmaceutical CDMO Services Market Size, 2017-2028
        6.5.3 Japan Pharmaceutical CDMO Services Market Size, 2017-2028
        6.5.4 South Korea Pharmaceutical CDMO Services Market Size, 2017-2028
        6.5.5 Southeast Asia Pharmaceutical CDMO Services Market Size, 2017-2028
        6.5.6 India Pharmaceutical CDMO Services Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Pharmaceutical CDMO Services Revenue, 2017-2028
        6.6.2 Brazil Pharmaceutical CDMO Services Market Size, 2017-2028
        6.6.3 Argentina Pharmaceutical CDMO Services Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Pharmaceutical CDMO Services Revenue, 2017-2028
        6.7.2 Turkey Pharmaceutical CDMO Services Market Size, 2017-2028
        6.7.3 Israel Pharmaceutical CDMO Services Market Size, 2017-2028
        6.7.4 Saudi Arabia Pharmaceutical CDMO Services Market Size, 2017-2028
        6.7.5 UAE Pharmaceutical CDMO Services Market Size, 2017-2028
7 Players Profiles
    7.1 Recipharm AB
        7.1.1 Recipharm AB Corporate Summary
        7.1.2 Recipharm AB Business Overview
        7.1.3 Recipharm AB Pharmaceutical CDMO Services Major Product Offerings
        7.1.4 Recipharm AB Pharmaceutical CDMO Services Revenue in Global Market (2017-2022)
        7.1.5 Recipharm AB Key News
    7.2 AMRI Global
        7.2.1 AMRI Global Corporate Summary
        7.2.2 AMRI Global Business Overview
        7.2.3 AMRI Global Pharmaceutical CDMO Services Major Product Offerings
        7.2.4 AMRI Global Pharmaceutical CDMO Services Revenue in Global Market (2017-2022)
        7.2.5 AMRI Global Key News
    7.3 Patheon N.V.
        7.3.1 Patheon N.V. Corporate Summary
        7.3.2 Patheon N.V. Business Overview
        7.3.3 Patheon N.V. Pharmaceutical CDMO Services Major Product Offerings
        7.3.4 Patheon N.V. Pharmaceutical CDMO Services Revenue in Global Market (2017-2022)
        7.3.5 Patheon N.V. Key News
    7.4 Aenova Group
        7.4.1 Aenova Group Corporate Summary
        7.4.2 Aenova Group Business Overview
        7.4.3 Aenova Group Pharmaceutical CDMO Services Major Product Offerings
        7.4.4 Aenova Group Pharmaceutical CDMO Services Revenue in Global Market (2017-2022)
        7.4.5 Aenova Group Key News
    7.5 Catalent, Inc.
        7.5.1 Catalent, Inc. Corporate Summary
        7.5.2 Catalent, Inc. Business Overview
        7.5.3 Catalent, Inc. Pharmaceutical CDMO Services Major Product Offerings
        7.5.4 Catalent, Inc. Pharmaceutical CDMO Services Revenue in Global Market (2017-2022)
        7.5.5 Catalent, Inc. Key News
    7.6 Amatsigroup
        7.6.1 Amatsigroup Corporate Summary
        7.6.2 Amatsigroup Business Overview
        7.6.3 Amatsigroup Pharmaceutical CDMO Services Major Product Offerings
        7.6.4 Amatsigroup Pharmaceutical CDMO Services Revenue in Global Market (2017-2022)
        7.6.5 Amatsigroup Key News
    7.7 WuXi AppTec Group
        7.7.1 WuXi AppTec Group Corporate Summary
        7.7.2 WuXi AppTec Group Business Overview
        7.7.3 WuXi AppTec Group Pharmaceutical CDMO Services Major Product Offerings
        7.7.4 WuXi AppTec Group Pharmaceutical CDMO Services Revenue in Global Market (2017-2022)
        7.7.5 WuXi AppTec Group Key News
    7.8 Strides Pharma Science Limited
        7.8.1 Strides Pharma Science Limited Corporate Summary
        7.8.2 Strides Pharma Science Limited Business Overview
        7.8.3 Strides Pharma Science Limited Pharmaceutical CDMO Services Major Product Offerings
        7.8.4 Strides Pharma Science Limited Pharmaceutical CDMO Services Revenue in Global Market (2017-2022)
        7.8.5 Strides Pharma Science Limited Key News
    7.9 Piramal Pharma Solutions
        7.9.1 Piramal Pharma Solutions Corporate Summary
        7.9.2 Piramal Pharma Solutions Business Overview
        7.9.3 Piramal Pharma Solutions Pharmaceutical CDMO Services Major Product Offerings
        7.9.4 Piramal Pharma Solutions Pharmaceutical CDMO Services Revenue in Global Market (2017-2022)
        7.9.5 Piramal Pharma Solutions Key News
    7.10 Siegfried Ltd
        7.10.1 Siegfried Ltd Corporate Summary
        7.10.2 Siegfried Ltd Business Overview
        7.10.3 Siegfried Ltd Pharmaceutical CDMO Services Major Product Offerings
        7.10.4 Siegfried Ltd Pharmaceutical CDMO Services Revenue in Global Market (2017-2022)
        7.10.5 Siegfried Ltd Key News
    7.11 Fareva Group
        7.11.1 Fareva Group Corporate Summary
        7.11.2 Fareva Group Business Overview
        7.11.3 Fareva Group Pharmaceutical CDMO Services Major Product Offerings
        7.11.4 Fareva Group Pharmaceutical CDMO Services Revenue in Global Market (2017-2022)
        7.11.5 Fareva Group Key News
    7.12 FAMAR Health Care Services
        7.12.1 FAMAR Health Care Services Corporate Summary
        7.12.2 FAMAR Health Care Services Business Overview
        7.12.3 FAMAR Health Care Services Pharmaceutical CDMO Services Major Product Offerings
        7.12.4 FAMAR Health Care Services Pharmaceutical CDMO Services Revenue in Global Market (2017-2022)
        7.12.5 FAMAR Health Care Services Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer
List of Tables
    Table 1. Pharmaceutical CDMO Services Market Opportunities & Trends in Global Market
    Table 2. Pharmaceutical CDMO Services Market Drivers in Global Market
    Table 3. Pharmaceutical CDMO Services Market Restraints in Global Market
    Table 4. Key Players of Pharmaceutical CDMO Services in Global Market
    Table 5. Top Pharmaceutical CDMO Services Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Pharmaceutical CDMO Services Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Pharmaceutical CDMO Services Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Pharmaceutical CDMO Services Product Type
    Table 9. List of Global Tier 1 Pharmaceutical CDMO Services Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Pharmaceutical CDMO Services Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Pharmaceutical CDMO Services Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Pharmaceutical CDMO Services Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Pharmaceutical CDMO Services Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Pharmaceutical CDMO Services Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Pharmaceutical CDMO Services Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Pharmaceutical CDMO Services Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Pharmaceutical CDMO Services Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Pharmaceutical CDMO Services Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Pharmaceutical CDMO Services Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Pharmaceutical CDMO Services Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Pharmaceutical CDMO Services Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Pharmaceutical CDMO Services Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Pharmaceutical CDMO Services Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Pharmaceutical CDMO Services Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Pharmaceutical CDMO Services Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Pharmaceutical CDMO Services Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Pharmaceutical CDMO Services Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Pharmaceutical CDMO Services Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Pharmaceutical CDMO Services Revenue, (US$, Mn), 2023-2028
    Table 30. Recipharm AB Corporate Summary
    Table 31. Recipharm AB Pharmaceutical CDMO Services Product Offerings
    Table 32. Recipharm AB Pharmaceutical CDMO Services Revenue (US$, Mn), (2017-2022)
    Table 33. AMRI Global Corporate Summary
    Table 34. AMRI Global Pharmaceutical CDMO Services Product Offerings
    Table 35. AMRI Global Pharmaceutical CDMO Services Revenue (US$, Mn), (2017-2022)
    Table 36. Patheon N.V. Corporate Summary
    Table 37. Patheon N.V. Pharmaceutical CDMO Services Product Offerings
    Table 38. Patheon N.V. Pharmaceutical CDMO Services Revenue (US$, Mn), (2017-2022)
    Table 39. Aenova Group Corporate Summary
    Table 40. Aenova Group Pharmaceutical CDMO Services Product Offerings
    Table 41. Aenova Group Pharmaceutical CDMO Services Revenue (US$, Mn), (2017-2022)
    Table 42. Catalent, Inc. Corporate Summary
    Table 43. Catalent, Inc. Pharmaceutical CDMO Services Product Offerings
    Table 44. Catalent, Inc. Pharmaceutical CDMO Services Revenue (US$, Mn), (2017-2022)
    Table 45. Amatsigroup Corporate Summary
    Table 46. Amatsigroup Pharmaceutical CDMO Services Product Offerings
    Table 47. Amatsigroup Pharmaceutical CDMO Services Revenue (US$, Mn), (2017-2022)
    Table 48. WuXi AppTec Group Corporate Summary
    Table 49. WuXi AppTec Group Pharmaceutical CDMO Services Product Offerings
    Table 50. WuXi AppTec Group Pharmaceutical CDMO Services Revenue (US$, Mn), (2017-2022)
    Table 51. Strides Pharma Science Limited Corporate Summary
    Table 52. Strides Pharma Science Limited Pharmaceutical CDMO Services Product Offerings
    Table 53. Strides Pharma Science Limited Pharmaceutical CDMO Services Revenue (US$, Mn), (2017-2022)
    Table 54. Piramal Pharma Solutions Corporate Summary
    Table 55. Piramal Pharma Solutions Pharmaceutical CDMO Services Product Offerings
    Table 56. Piramal Pharma Solutions Pharmaceutical CDMO Services Revenue (US$, Mn), (2017-2022)
    Table 57. Siegfried Ltd Corporate Summary
    Table 58. Siegfried Ltd Pharmaceutical CDMO Services Product Offerings
    Table 59. Siegfried Ltd Pharmaceutical CDMO Services Revenue (US$, Mn), (2017-2022)
    Table 60. Fareva Group Corporate Summary
    Table 61. Fareva Group Pharmaceutical CDMO Services Product Offerings
    Table 62. Fareva Group Pharmaceutical CDMO Services Revenue (US$, Mn), (2017-2022)
    Table 63. FAMAR Health Care Services Corporate Summary
    Table 64. FAMAR Health Care Services Pharmaceutical CDMO Services Product Offerings
    Table 65. FAMAR Health Care Services Pharmaceutical CDMO Services Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Pharmaceutical CDMO Services Segment by Type in 2021
    Figure 2. Pharmaceutical CDMO Services Segment by Application in 2021
    Figure 3. Global Pharmaceutical CDMO Services Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Pharmaceutical CDMO Services Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Pharmaceutical CDMO Services Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Pharmaceutical CDMO Services Revenue in 2021
    Figure 8. By Type - Global Pharmaceutical CDMO Services Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Pharmaceutical CDMO Services Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Pharmaceutical CDMO Services Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Pharmaceutical CDMO Services Revenue Market Share, 2017-2028
    Figure 12. US Pharmaceutical CDMO Services Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Pharmaceutical CDMO Services Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Pharmaceutical CDMO Services Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Pharmaceutical CDMO Services Revenue Market Share, 2017-2028
    Figure 16. Germany Pharmaceutical CDMO Services Revenue, (US$, Mn), 2017-2028
    Figure 17. France Pharmaceutical CDMO Services Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Pharmaceutical CDMO Services Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Pharmaceutical CDMO Services Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Pharmaceutical CDMO Services Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Pharmaceutical CDMO Services Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Pharmaceutical CDMO Services Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Pharmaceutical CDMO Services Revenue Market Share, 2017-2028
    Figure 24. China Pharmaceutical CDMO Services Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Pharmaceutical CDMO Services Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Pharmaceutical CDMO Services Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Pharmaceutical CDMO Services Revenue, (US$, Mn), 2017-2028
    Figure 28. India Pharmaceutical CDMO Services Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Pharmaceutical CDMO Services Revenue Market Share, 2017-2028
    Figure 30. Brazil Pharmaceutical CDMO Services Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Pharmaceutical CDMO Services Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Pharmaceutical CDMO Services Revenue Market Share, 2017-2028
    Figure 33. Turkey Pharmaceutical CDMO Services Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Pharmaceutical CDMO Services Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Pharmaceutical CDMO Services Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Pharmaceutical CDMO Services Revenue, (US$, Mn), 2017-2028
    Figure 37. Recipharm AB Pharmaceutical CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. AMRI Global Pharmaceutical CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Patheon N.V. Pharmaceutical CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Aenova Group Pharmaceutical CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Catalent, Inc. Pharmaceutical CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Amatsigroup Pharmaceutical CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. WuXi AppTec Group Pharmaceutical CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Strides Pharma Science Limited Pharmaceutical CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Piramal Pharma Solutions Pharmaceutical CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Siegfried Ltd Pharmaceutical CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. Fareva Group Pharmaceutical CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 48. FAMAR Health Care Services Pharmaceutical CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
63
Frequently Asked Questions
Pharmaceutical CDMO Services Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Pharmaceutical CDMO Services Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Pharmaceutical CDMO Services Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports